Physician profile
Robert J Schmitz
NPI 1548218183
$2,413.56
in general payments reported to CMS, 2019-2025
13 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $33.39 · 2022: $106 · 2023: $241 · 2024: $806 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234 · Travel and Lodging: $815 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,234.42 |
| Travel and Lodging | $814.83 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $1,175.04 | 2024-2025 | |
| Abbvie INC. | $454.24 | 2022-2024 | Skyrizi, Rinvoq |
| Pentax of America, INC. | $200.06 | 2020-2024 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Pfizer INC. | $135.13 | 2019-2025 | |
| Madrigal Pharmaceuticals | $131.84 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $107.98 | 2019-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $73.05 | 2023-2025 | Dupixent |
| Janssen Biotech, INC. | $39.05 | 2019-2025 | Simponi, Simponi Aria, Tremfya |
| Ironwood Pharmaceuticals, INC | $30.47 | 2020-2023 | Linzess |
| Gilead Sciences, INC. | $19.43 | 2024 | |
| Romark Laboratories, Lc | $16.92 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.88 | 2025 | Givlaari |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.